Related Experiment Videos
Absence of DNA repair deficiency in the confirmed heterozygotes of xeroderma pigmentosum group A
S Moriwaki1, C Nishigori, T Teramoto
1Department of Dermatology, Faculty of Medicine, Kyoto, Japan.
Abstract:
This study was performed to elucidate whether xeroderma pigmentosum complementation group A (XPA) carrier has DNA repair abnormality against sun-exposure and ultraviolet (UV)-mimetic chemical carcinogen 4-nitroquinoline 1-oxide (4NQO). Here we report three sporadic cases of XP that were defined as group A by genetic complementation test as well as polymerase chain reaction (PCR) analysis to detect the point mutation in the responsible gene for XPA. DNA repair analyses in the skin fibroblasts revealed that the cells from the patients were much more sensitive to UV and 4NQO and had extremely low UV-induced unscheduled DNA synthesis (UDS) than control cells, whereas the cells from the carriers (heterozygotes of XP) had sensitivity to UV and 4NQO and levels of UV-induced UDS similar to normal cells. These results indicate that the obligate heterozygotes, despite having a mutated allele in XPA complementing gene demonstrated by PCR, have no DNA repair abnormality after UV irradiation and UV-mimetic 4NQO treatment. Our observations imply that XPA heterozygotes do not have higher risk of skin cancers than normal subjects based on their DNA repair abnormality.
Insights
Xeroderma pigmentosum complementation group A (XPA) carriers, despite having a mutated gene, show no DNA repair defects against UV radiation or carcinogens. This suggests XPA heterozygotes do not face an increased skin cancer risk due to DNA repair abnormalities.
Area of Science:
- Genetics
- Molecular Biology
- Dermatology
Background:
- Investigating DNA repair mechanisms in Xeroderma Pigmentosum (XP) is crucial for understanding UV-induced DNA damage.
- Xeroderma Pigmentosum complementation group A (XPA) is a key gene in nucleotide excision repair.
- Assessing DNA repair capacity in XPA carriers (heterozygotes) is important for risk assessment.
Observation:
- Three sporadic XP cases were identified as complementation group A via genetic testing and PCR analysis.
- Skin fibroblasts from XP patients exhibited hypersensitivity to UV and 4-nitroquinoline 1-oxide (4NQO), with significantly reduced UV-induced unscheduled DNA synthesis (UDS).
- Fibroblasts from XPA carriers showed normal sensitivity and UV-induced UDS levels comparable to control cells.
Findings:
- XPA carriers (heterozygotes) demonstrated no discernible DNA repair abnormalities following UV irradiation or 4NQO exposure.
- Despite possessing a mutated XPA allele, heterozygotes maintained functional DNA repair capacity.
- The study confirms that XPA gene mutations in heterozygotes do not impair DNA repair processes.
Implications:
- XPA heterozygotes do not appear to have an elevated risk of skin cancer stemming from DNA repair deficiencies.
- These findings contribute to a better understanding of XP genetics and cancer risk stratification.
- Further research may explore other factors influencing cancer risk in XPA carriers.